SAO · RDOR3.SA
Rede D'Or São Luiz S.A.
R$31.59-R$0.76 (-2.35%)
Rede D'Or São Luiz S.A.’s quoted price sits in the lower half of its reported 52-week range, 34.74% below the high.
Loading market information…
SAO · AALR3.SA · BRL
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:54 PM UTC. Cached market data; not a live quote.
One-year closing-price history · BRL. Historical prices are not a forecast.
Allianca Saude e Participacoes S.A.’s quoted price sits in the lower half of its reported 52-week range, 60.1% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Allianca Saude e Participacoes S.A.’s next earnings report is currently expected on Nov 13, 2026, with estimated earnings per share of R$0.05. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Allianca Saude e Participacoes S.A.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Alliança Saúde e Participações S.A. functions as a holding entity primarily focused on delivering medical diagnostic services. Its comprehensive service portfolio encompasses diagnostic imaging, record-based assessments, nuclear medicine procedures, cytological analysis, anatomical pathology, and a range of clinical laboratory tests. Geraldo Mol Starling Filho established the organization on August 5, 1992, and its central operations are located in Sao Paulo, Brazil.
Latest available per-share figures in BRL. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:18 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| R$288.19M |
KEEP COMPARING
R$31.59-R$0.76 (-2.35%)
Rede D'Or São Luiz S.A.’s quoted price sits in the lower half of its reported 52-week range, 34.74% below the high.
R$3.01+R$0.06 (+2.03%)
Diagnósticos da América S.A.’s quoted price sits in the lower half of its reported 52-week range, 48.01% below the high.
R$10.12-R$0.17 (-1.65%)
Dimed S.A. Distribuidora de Medicamentos’s quoted price sits in the lower half of its reported 52-week range, 38.93% below the high.
R$0.76+R$0.05 (+7.04%)
Oncoclínicas do Brasil Serviços Médicos S.A.’s quoted price sits in the lower half of its reported 52-week range, 74.92% below the high.
R$6.69+R$0.09 (+1.36%)
Profarma Distribuidora de Produtos Farmacêuticos S.A.’s quoted price sits in the lower half of its reported 52-week range, 31.03% below the high.
R$5.38+R$0.03 (+0.56%)
Biomm S.A.’s quoted price sits in the lower half of its reported 52-week range, 44.82% below the high.
R$1.32+R$0.02 (+1.54%)
Qualicorp Consultoria e Corretora de Seguros S.A.’s quoted price sits in the lower half of its reported 52-week range, 51.65% below the high.
R$15.05+R$0.24 (+1.62%)
Baumer S.A.’s quoted price sits in the lower half of its reported 52-week range, 39.8% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
